VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
about
Cancer Transcriptome Dataset Analysis: Comparing Methods of Pathway and Gene Regulatory Network-Based Cluster Identification.Association of -460C/T and +405 G/C polymorphisms of vascular endothelial growth factor gene and susceptibility to ovarian hyperstimulation syndromePolymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study.The influence of the CHIEF pathway on colorectal cancer-specific mortalityA pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.The Effect of FLT1 Variant on Long-Term Cardiovascular Outcomes: Validation of a Locus Identified in a Previous Genome-Wide Association Study.A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and SurvivalFLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis.Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.No associations of a set of SNPs in the Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase (MMP) genes with survival of colorectal cancer patientsmicroRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A.A novel kinase mutation in VEGFR-1 predisposes its αC-helix/activation loop towards allosteric activation: Atomic insights from protein simulation.
P2860
Q33569864-0AF0C11A-F48C-4595-9FF9-D77E69CC5CF6Q33603790-F3B344FE-2245-49D5-A3DC-B4B7D7999D43Q33645770-2E9EEE0E-3B25-4AC3-B2BB-A8829C1B2403Q34777098-CC097285-BC94-424D-A130-EB664B6102DCQ34917952-E7BAB2F2-92A6-4083-BDB6-35A5C2CD85EBQ35669479-2E358D5B-25F5-4854-BC3C-03E4AC6CCD5DQ36162743-086F1A0A-6156-42D7-85F0-6F7A928AE7CAQ36294953-2810F155-788F-4DAD-8840-FEC4E74E5FECQ36316634-3E344D7F-CEAC-4EBB-B17A-9A00773B524CQ36841039-4D95FB46-8088-42DF-9211-AF77551A39D8Q37321136-C7723394-0363-43EF-95CA-E8963C78C840Q38796985-7B8CFBBB-CF9F-41C6-8E62-7AF8DAC7E299Q41691274-2ED40BC6-513E-45D8-AA64-410C45788A15
P2860
VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@en
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@nl
type
label
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@en
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@nl
prefLabel
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@en
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@nl
P2860
P356
P1476
VEGFA, FLT1, KDR and colorecta ...... cular phenotype, and survival.
@en
P2093
Abbie Lundgreen
Roger K Wolff
P2860
P304
P356
10.1002/MC.22058
P478
53 Suppl 1
P577
2013-06-21T00:00:00Z